Yoshitaka Inoue1, Yong-Ming Yu, Tomohiro Kurihara, Aleksandr Vasilyev, Amir Ibrahim, Rahmi Oklu, Gaofeng Zhao, Anil V Nair, Dennis Brown, Alan J Fischman, Ronald G Tompkins, Daniel Irimia. 1. 1Department of Surgery, Massachusetts General Hospital, Boston, MA. 2Shriners Hospital for Children, Boston, MA. 3Harvard Medical School, Boston, MA. 4Department of Pathology, Massachusetts General Hospital, Boston, MA. 5Nephrology Division, Department of Medicine, Massachusetts General Hospital, Boston, MA. 6Department of Interventional Radiology, Massachusetts General Hospital, Boston, MA. 7Program in Membrane Biology, Division of Nephrology and Center for Systems Biology, Massachusetts General Hospital, Boston, MA. 8Department of Nuclear Medicine, Massachusetts General Hospital, Boston, MA. 9BioMEMS Resource Center, Massachusetts General Hospital, Boston, MA.
Abstract
OBJECTIVES: Innate immune dysfunction after major burn injuries increases the susceptibility to organ failure. Lipid mediators of inflammation resolution, e.g., resolvin D2, have been shown recently to restore neutrophil functionality and reduce mortality rate in a rat model of major burn injury. However, the physiological mechanisms responsible for the benefic activity of resolvin D2 are not well understood. DESIGN: Prospective randomized animal investigation. SETTING: Academic research setting. SUBJECTS: Wistar male rats. INTERVENTIONS: Animals were subjected to a full-thickness burn of 30% total body surface area. Two hours after burn, 25 ng/kg resolvin D2 was administered IV and repeated every day, for 8 days. At day 10 post burn, 2 mg/kg of lipopolysaccharide was administered IV, and the presence of renal and hepatic injuries was evaluated at day 11 post burn by histology, immunohistochemistry, and relevant blood chemistry. MEASUREMENTS AND MAIN RESULTS: In untreated animals, we found significant tissue damage in the kidneys and liver, consistent with acute tubular necrosis and multifocal necrosis, and changes in blood chemistry, reflecting the deterioration of renal and hepatic functions. We detected less tissue damage and significantly lower values of blood urea nitrogen (26.4 ± 2.1 vs 36.0 ± 9.3 mg/dL; p ≤ 0.001), alanine aminotransferase (266.5 ± 295.2 vs 861.8 ± 813.7 U/L; p ≤ 0.01), and total bilirubin (0.13 ± 0.05 vs 0.30 ± 0.14 mg/dL; p ≤ 0.01) in resolvin D2-treated rats than in untreated animals. The mean blood pressure of all animals was above 65 mm Hg, indicating adequate tissue perfusion throughout the experiments. We measured significantly larger amounts of chromatin in the circulation of untreated than of resolvin D2-treated rats (575.1 ± 331.0 vs 264.1 ± 122.4 ng/mL; p ≤ 0.05) and identified neutrophil extracellular traps in kidney and liver tissues from untreated rats, consistent with the tissue damage. CONCLUSIONS: Pathologic changes in kidney and liver tissues in a rat model of major burn and endotoxin insults are ameliorated by resolvin D2.
OBJECTIVES: Innate immune dysfunction after major burn injuries increases the susceptibility to organ failure. Lipid mediators of inflammation resolution, e.g., resolvin D2, have been shown recently to restore neutrophil functionality and reduce mortality rate in a rat model of major burn injury. However, the physiological mechanisms responsible for the benefic activity of resolvin D2 are not well understood. DESIGN: Prospective randomized animal investigation. SETTING: Academic research setting. SUBJECTS: Wistar male rats. INTERVENTIONS: Animals were subjected to a full-thickness burn of 30% total body surface area. Two hours after burn, 25 ng/kg resolvin D2 was administered IV and repeated every day, for 8 days. At day 10 post burn, 2 mg/kg of lipopolysaccharide was administered IV, and the presence of renal and hepatic injuries was evaluated at day 11 post burn by histology, immunohistochemistry, and relevant blood chemistry. MEASUREMENTS AND MAIN RESULTS: In untreated animals, we found significant tissue damage in the kidneys and liver, consistent with acute tubular necrosis and multifocal necrosis, and changes in blood chemistry, reflecting the deterioration of renal and hepatic functions. We detected less tissue damage and significantly lower values of blood ureanitrogen (26.4 ± 2.1 vs 36.0 ± 9.3 mg/dL; p ≤ 0.001), alanine aminotransferase (266.5 ± 295.2 vs 861.8 ± 813.7 U/L; p ≤ 0.01), and total bilirubin (0.13 ± 0.05 vs 0.30 ± 0.14 mg/dL; p ≤ 0.01) in resolvin D2-treated rats than in untreated animals. The mean blood pressure of all animals was above 65 mm Hg, indicating adequate tissue perfusion throughout the experiments. We measured significantly larger amounts of chromatin in the circulation of untreated than of resolvin D2-treated rats (575.1 ± 331.0 vs 264.1 ± 122.4 ng/mL; p ≤ 0.05) and identified neutrophil extracellular traps in kidney and liver tissues from untreated rats, consistent with the tissue damage. CONCLUSIONS: Pathologic changes in kidney and liver tissues in a rat model of major burn and endotoxin insults are ameliorated by resolvin D2.
Authors: Takuya Miyahara; Sara Runge; Anuran Chatterjee; Mian Chen; Giorgio Mottola; Jonathan M Fitzgerald; Charles N Serhan; Michael S Conte Journal: FASEB J Date: 2013-02-13 Impact factor: 5.191
Authors: Daniel J McIlroy; Andrew G Jarnicki; Gough G Au; Natalie Lott; Doug W Smith; Philip M Hansbro; Zsolt J Balogh Journal: J Crit Care Date: 2014-07-22 Impact factor: 3.425
Authors: Refika Hamutcu; Jon M Rowland; Monica V Horn; Cornelia Kaminsky; Eithne F MacLaughlin; Vaughn A Starnes; Marlyn S Woo Journal: Am J Respir Crit Care Med Date: 2002-04-15 Impact factor: 21.405
Authors: Li Diao; Alexandra H Marshall; Xiaojing Dai; Elena Bogdanovic; Abdikarim Abdullahi; Saeid Amini-Nik; Marc G Jeschke Journal: Shock Date: 2014-02 Impact factor: 3.454
Authors: Jens Altrichter; Siegfried Zedler; Robert Kraft; Eugen Faist; Steffen R Mitzner; Martin Sauer; Joachim Windolf; Martin Scholz; Tim Lögters Journal: Eur J Trauma Emerg Surg Date: 2010-03-17 Impact factor: 3.693
Authors: Yoshitaka Inoue; Yuk Ming Liu; Masayuki Otawara; Isabel Chico Calero; Ahhyun Stephanie Nam; Yong-Ming Yu; Philip Chang; Kathryn L Butler; Rosalynn M Nazarian; Jeremy Goverman; Benjamin J Vakoc; Daniel Irimia Journal: J Burn Care Res Date: 2018-04-20 Impact factor: 1.845
Authors: Ahmed A Elmarakby; Ahmed S Ibrahim; Mohamed A Katary; Nehal M Elsherbiny; Mohamed El-Shafey; Ahmed M Abd-Elrazik; Rafik A Abdelsayed; Krishna Rao Maddipati; Mohamed Al-Shabrawey Journal: Biochim Biophys Acta Mol Cell Biol Lipids Date: 2019-07-23 Impact factor: 4.698
Authors: Florent Artru; Mark J W McPhail; Evangelos Triantafyllou; Francesca Maria Trovato Journal: Front Immunol Date: 2022-03-31 Impact factor: 7.561
Authors: R Ma; T Li; M Cao; Y Si; X Wu; L Zhao; Z Yao; Y Zhang; S Fang; R Deng; V A Novakovic; Y Bi; J Kou; B Yu; S Yang; J Wang; J Zhou; J Shi Journal: Cell Death Dis Date: 2016-06-30 Impact factor: 8.469